Tab. Eziride
Chewable Tablet · PO · 150mcg / chewable tablet · 1 chewable tablet
৳5
Tab.
Eziride
Hyoscine Hydrobromide
— Opsonin Pharma Ltd.
150mcg / chewable tablet
Presentations
Dose rules
No structured dose rules are linked to this brand yet.
Dose reference
Human
Adults and children over 13 years: 2 tablets (Maximum 4 tablets in 24 hours).Children age 7-12 years: 1-2 tablets (Maximum 2 tablets in 24 hours).Children age 4-7 years: 1 tablet (Maximum 2 tablets in 24 hours).Children age 3-4 years: half a tablet (Maximum 1 tablet in 24 hours).Children under 3 years: Not recommended under 3 years or as directed by the physician.
Administration: Ideally, take tablets 30 minutes before the journey.
Clinical notes
Applications:
N/A
Indication Notes:
Hyoscine Hydrobromide is indicated in the prevention and control of nausea and vomiting associated with motion sickness/travel sickness.
Avoid In:
N/A
Contraindication Notes:
Hyoscine Hydrobromide is contraindicated in Glaucoma/Blindness.
Hyoscine Hydrobromide is a type of medicine called an antimuscarinic (or anticholinergic). Hyoscine hydrobromide is sometimes known as scopolamine. It is thought to prevent motion sickness by stopping the messages sent from the vestibular system to reach an area of the brain called the vomiting centre. This area of the brain coordinates the vomiting reflex.
Additive sedative effects with alcohol or other CNS depressants. Reduced effects with acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine, tacrine).
Dry mouth, dizziness, blurred vision, difficulty with micturition.
Not recommended during pregnancy and lactation.
May cause drowsiness, if affected do not drive or operate machinery. May be potentiated by concurrent phenothiazines, tricyclic antidepressants or alcohol. Absorption may be reduced by aluminium hydroxide preparations.
Children: This product only be given to children over 3 years old